King & Spalding: TVM Capital invests in Boston Oncology

King & Spalding advised TVM Capital Healthcare on its $35 million investment into Boston Oncology Arabia, a manufacturer and distributor of biogeneric drugs operating in Saudi Arabia. The investment into Boston Oncology Arabia helps to increase TVM Capital Healthcare’s footprint within Saudi Arabia.

King & Spalding’s team

A team of lawyers from Riyadh, Dubai, Atlanta, and London offices advised TVM Capital Healthcare on the transaction. The team included partner Martin Hunt (pictured left) managing partner Nabil A. Issa (pictured right), counsel Sunandini Das, senior associate Saud Aldawsari, senior associate Mohammed Basama, associate Jamie Kershaw, associate Husni Al Far, associate Michael Nunnally (based in Atlanta) and Katie Munro.

TVM Capital

TVM Capital Healthcare, a Dubai-based specialist investment management firm, operates within the healthcare sector and its investment strategy is built around becoming a strategic partner of companies in the sector by injecting equity capital and acting as a highly active shareholder.